Supriya Lifescience Ltd
NSE:SUPRIYA

Watchlist Manager
Supriya Lifescience Ltd Logo
Supriya Lifescience Ltd
NSE:SUPRIYA
Watchlist
Price: 706.75 INR -0.6% Market Closed
Market Cap: 56.9B INR
Have any thoughts about
Supriya Lifescience Ltd?
Write Note

Supriya Lifescience Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Supriya Lifescience Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Supriya Lifescience Ltd
NSE:SUPRIYA
Cash from Operating Activities
₹1.1B
CAGR 3-Years
14%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash from Operating Activities
₹34.1B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash from Operating Activities
₹45B
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash from Operating Activities
₹127.2B
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash from Operating Activities
₹34.1B
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Cash from Operating Activities
₹21.5B
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Supriya Lifescience Ltd
Glance View

Market Cap
56.9B INR
Industry
Pharmaceuticals

Supriya Lifescience Ltd. supplies active pharmaceuticals ingredients (“APIs”), with a focus on research and development. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2021-12-28. The company focuses on products in various therapeutic segments, such as Anti-Histamine, Anti-Allergics, Vitamins, Anesthetics and Anti-Asthmatics. Its manufacturing facilities include delineated areas for quality check (QC); manufacturing areas with multiple clean rooms; engineering and maintenance; warehouse; materials and finished goods stores; in-house microbiological laboratory, and functional waste treatment plant. The company handles chemical reactions, such as Friedel Craft’s Acylation, Claisen Condensation, Grignard Reaction, Mannich Reaction, Ritter Reaction, Eschweiler Clark reaction, Hydrogenation, Chlorination, Bromination, Decyanation, Isocyanation, Ethoxylation, Nitration, Alkylation, Reduction, Oxidation, Etherification, Chlorosulphonation, Phosphorylation, Chiral resolution, Heterocyclic chemistry, Thermal ring expansion and Protection/Deprotection.

SUPRIYA Intrinsic Value
448.33 INR
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Supriya Lifescience Ltd's Cash from Operating Activities?
Cash from Operating Activities
1.1B INR

Based on the financial report for Mar 31, 2024, Supriya Lifescience Ltd's Cash from Operating Activities amounts to 1.1B INR.

What is Supriya Lifescience Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
18%

Over the last year, the Cash from Operating Activities growth was 71%. The average annual Cash from Operating Activities growth rates for Supriya Lifescience Ltd have been 14% over the past three years , 18% over the past five years .

Back to Top